News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ApoCell, Inc. Awarded $2.9 Million from SAIC-Frederick, Inc. (SAI) to Deliver a New Platform for Detection and Molecular Analysis of Circulating Tumor Cells (CTCs) to the National Cancer Institute’s Pharmacodynamics Program



8/10/2011 10:31:50 AM

HOUSTON--(BUSINESS WIRE)--ApoCell, Inc. announced the award of a $2.9 million contract from SAIC-Frederick Inc. (SAIC-F), in support of the National Cancer Institute, for the development and delivery of 12 alpha prototype units of the ApoCell DEP-FFF circulating tumor cell (CTC) detection system, called ApoStreamâ„¢. The project, funded by the American Recovery and Reinvestment Act (ARRA), is for the delivery of technology for CTC capture and analysis to determine the effects of targeted cancer therapies.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES